iMD Companies, Inc. (ICBU)
USD 0.0
(-4.44%)
USD 0.0
(-4.44%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.67 Million USD | 5.96% |
| 2022 | 1.58 Million USD | 5.87% |
| 2021 | 1.49 Million USD | 54.21% |
| 2020 | 967.78 Thousand USD | -1.2% |
| 2019 | 979.51 Thousand USD | 4.19% |
| 2018 | 940.12 Thousand USD | -91.46% |
| 2017 | 11 Million USD | -0.99% |
| 2016 | 11.11 Million USD | 677.87% |
| 2015 | 1.42 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.73 Million USD | 3.1% |
| 2024 Q1 | 1.68 Million USD | 0.59% |
| 2023 FY | 1.67 Million USD | 5.96% |
| 2023 Q4 | 1.67 Million USD | 1.61% |
| 2023 Q1 | 1.59 Million USD | 1.21% |
| 2023 Q2 | 1.61 Million USD | 1.12% |
| 2023 Q3 | 1.64 Million USD | 1.89% |
| 2022 Q1 | 1.42 Million USD | -4.27% |
| 2022 FY | 1.58 Million USD | 5.87% |
| 2022 Q4 | 1.58 Million USD | 2.76% |
| 2022 Q2 | 1.51 Million USD | 6.23% |
| 2022 Q3 | 1.53 Million USD | 1.3% |
| 2021 Q2 | 1.26 Million USD | 21.05% |
| 2021 FY | 1.49 Million USD | 54.21% |
| 2021 Q1 | 1.04 Million USD | 0.0% |
| 2021 Q4 | 1.49 Million USD | 15.05% |
| 2021 Q3 | 1.29 Million USD | 2.36% |
| 2020 FY | 967.78 Thousand USD | -1.2% |
| 2019 FY | 979.51 Thousand USD | 4.19% |
| 2018 FY | 940.12 Thousand USD | -91.46% |
| 2017 FY | 11 Million USD | -0.99% |
| 2016 FY | 11.11 Million USD | 677.87% |
| 2015 FY | 1.42 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | 53.597% |
| Arrayit Corporation | 7.49 Million USD | 77.667% |
| Atlantic International Corp. | 3.82 Million USD | 56.271% |
| Biocept, Inc. | 22.01 Million USD | 92.394% |
| Bioqual, Inc. | 18.93 Million USD | 91.159% |
| CardioGenics Holdings Inc | 1.79 Million USD | 6.725% |
| DermTech, Inc. | 64.75 Million USD | 97.415% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 99.772% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | 86.483% |
| IDenta Corp. | 1.01 Million USD | -65.247% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 94.054% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -461.917% |
| InVitro International | 78.99 Thousand USD | -2019.529% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | 91.514% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -1194.861% |
| Medical Imaging Corp. | 9.51 Million USD | 82.408% |
| NovelStem International Corp. | 4.2 Million USD | 60.195% |
| Optigenex Inc. | 9.57 Million USD | 82.507% |
| PharmChem, Inc. | 558.64 Thousand USD | -199.691% |
| Proteome Sciences plc | 18.48 Million USD | 90.945% |
| Response Genetics, Inc | 15.86 Million USD | 89.448% |
| Rennova Health, Inc. | 49.66 Million USD | 96.629% |
| RushNet, Inc. | 6.23 Million USD | 73.165% |
| ScreenPro Security Inc. | 1.6 Million USD | -4.6% |
| Stella Diagnostics Inc. | 18 Million USD | 90.702% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | 79.593% |
| Todos Medical Ltd. | 50.15 Million USD | 96.662% |